These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37608033)
1. METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway. Xu M; Yu J; Liu X; Jia W; Duan Y; Ma D; Ma J; Lei W; Tai W Med Oncol; 2023 Aug; 40(9):274. PubMed ID: 37608033 [TBL] [Abstract][Full Text] [Related]
2. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
3. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Liu X; Sun L; Zhang S; Zhang S; Li W J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350 [TBL] [Abstract][Full Text] [Related]
6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma. Xue F; Jia Y; Zhao J Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075 [TBL] [Abstract][Full Text] [Related]
8. METTL3-mediated m Zhou YF; Li JT; Zheng QL; Ren KL; Yi CC Kaohsiung J Med Sci; 2024 Feb; 40(2):150-160. PubMed ID: 38088510 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway. Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484 [TBL] [Abstract][Full Text] [Related]
10. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. Gao BB; Wang SX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077 [TBL] [Abstract][Full Text] [Related]
11. TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells. Zhao ZQ; Wu XJ; Cheng YH; Zhou YF; Ma XM; Zhang J; Heng XY; Feng F CNS Neurosci Ther; 2021 Jun; 27(9):1064-76. PubMed ID: 34077623 [TBL] [Abstract][Full Text] [Related]
12. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt. Chen Y; Wu L; Bao M Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369 [TBL] [Abstract][Full Text] [Related]
13. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. Wu Q; Wang YB; Che XW; Wang H; Wang W J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006 [TBL] [Abstract][Full Text] [Related]
14. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway. Wang X; Huang M; Xie W; Ding Q; Wang T J Biosci; 2023; 48():. PubMed ID: 36695419 [TBL] [Abstract][Full Text] [Related]
15. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188 [TBL] [Abstract][Full Text] [Related]
16. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma. Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764 [TBL] [Abstract][Full Text] [Related]
17. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628 [TBL] [Abstract][Full Text] [Related]
18. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X PeerJ; 2022; 10():e14206. PubMed ID: 36275477 [TBL] [Abstract][Full Text] [Related]
19. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway. Li R; Chai L; Lei L; Guo R; Wen X Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073 [TBL] [Abstract][Full Text] [Related]
20. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer. Zhan Y; Chen R; Wang T; Shan S; Zhu H Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]